Literature DB >> 9138840

A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II.

L J Shaw1, E L Eisenstein, R Hachamovitch, G V Heller, D D Miller.   

Abstract

Mesh：

Year:  1997        PMID： 9138840     DOI： 10.1016/s1071-3581(97)90049-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  20 in total

1.  Nonionic contrast media: a bargain for some, a burden for many.

Authors:  V Goel; R B Deber; A S Detsky
Journal:  CMAJ       Date:  1990-09-15       Impact factor: 8.262

2.  The journal's policy on cost-effectiveness analyses.

Authors:  J P Kassirer; M Angell
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

Review 3.  Clinical economics. A guide to the economic analysis of clinical practices.

Authors:  J M Eisenberg
Journal:  JAMA       Date:  1989-11-24       Impact factor: 56.272

4.  Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology.

Authors: 
Journal:  Ann Intern Med       Date:  1995-07-01       Impact factor: 25.391

5.  The distinction between cost and charges.

Authors:  S A Finkler
Journal:  Ann Intern Med       Date:  1982-01       Impact factor: 25.391

6.  Quality of life six months after myocardial infarction treated with thrombolytic therapy. AUS-TASK Group. Australian arm of International tPA/SK Mortality Trial.

Authors:  P P Glasziou; S Bromwich; R J Simes
Journal:  Med J Aust       Date:  1994-11-07       Impact factor: 7.738

7.  Gender-related differences in clinical management after exercise nuclear testing.

Authors:  R Hachamovitch; D S Berman; H Kiat; N Bairey-Merz; I Cohen; J A Cabico; J D Friedman; G Germano; K F Van Train; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1995-11-15       Impact factor: 24.094

8.  Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography.

Authors:  N R Powe; A J Davidoff; R D Moore; J A Brinker; G F Anderson; M R Litt; R Gopalan; S L Graziano; E P Steinberg
Journal:  J Am Coll Cardiol       Date:  1993-06       Impact factor: 24.094

9.  Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery.

Authors:  D J Cohen; J A Breall; K K Ho; R M Weintraub; R E Kuntz; M C Weinstein; D S Baim
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

10.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.

Authors:  D B Mark; M A Hlatky; R M Califf; C D Naylor; K L Lee; P W Armstrong; G Barbash; H White; M L Simoons; C L Nelson
Journal:  N Engl J Med       Date:  1995-05-25       Impact factor: 91.245
View more
  10 in total

Review 1.  Statistical analysis of medical data. Part I: Univariable analysis.

Authors:  R Hachamovitch; C Shufelt
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 2.  Clinical and economic outcomes assessment with myocardial contrast echocardiography.

Authors:  L J Shaw; M J Monaghan; P Nihoyannopolous
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

3.  Treadmill test scores: attributes and limitations.

Authors:  L J Shaw; R Hachamovitch; A E Iskandrian
Journal:  J Nucl Cardiol       Date:  1997 Jan-Feb       Impact factor: 5.952

Review 4.  Myocardial perfusion scintigraphy and cost effectiveness of diagnosis and management of coronary heart disease.

Authors:  S R Underwood; L J Shaw; C Anagnostopoulos; M Cerqueira; P J Ell; J Flint; M Harbinson; A Kelion; A Al Mohammad; E M Prvulovich
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 5.  Prognostic value of gated myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

6.  Prognostic characterization of patients with mild coronary artery disease with myocardial perfusion single photon emission computed tomography: validation of an outcomes-based strategy.

Authors:  R Hachamovitch
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

7.  Cardiovascular risk assessment models: Have we found the perfect solution yet?

Authors:  Aiden Abidov; Omar Chehab
Journal:  J Nucl Cardiol       Date:  2019-02-21       Impact factor: 5.952

8.  Risk-sensitive therapeutic strategies for coronary artery disease: toward testing-driven therapy in stable angina patients with low-to-intermediate risk cardiac imaging results.

Authors:  D D Miller; B J Gersh
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

9.  Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group.

Authors:  L J Shaw; G V Heller; M I Travin; M Lauer; T Marwick; R Hachamovitch; D S Berman; D D Miller
Journal:  J Nucl Cardiol       Date:  1999 Nov-Dec       Impact factor: 5.952

Review 10.  Myocardial perfusion scintigraphy: the evidence.

Authors:  S R Underwood; C Anagnostopoulos; M Cerqueira; P J Ell; E J Flint; M Harbinson; A D Kelion; A Al-Mohammad; E M Prvulovich; L J Shaw; A C Tweddel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.